Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Sales | 13,109 | 10,778 | 11,842 | 13,700 | 12,111 |
| Gross Profit | 13,109 | 10,778 | 11,842 | 13,700 | 12,111 |
| Operating Expenses | 27,058 | 27,222 | 27,445 | 26,041 | 26,979 |
| Operating Income | -13,949 | -16,444 | -15,603 | -12,341 | -14,868 |
| Interest Expense | 833 | 705 | 291 | 85 | 76 |
| Other Income | 405 | 361 | 428 | 626 | 386 |
| Pre-tax Income | -14,377 | -16,788 | -15,466 | -11,800 | -14,558 |
| Net Income Continuous | -14,377 | -16,788 | -15,466 | -11,800 | -14,558 |
| Net Income | $-14,377 | $-16,788 | $-15,466 | $-14,876 | $-14,558 |
| EPS Basic Total Ops | -1.61 | -1.82 | -1.75 | -1.54 | -1.68 |
| EPS Basic Continuous Ops | -1.59 | -1.85 | -1.72 | -1.21 | -1.71 |
| EPS Diluted Total Ops | -1.61 | -1.82 | -1.75 | -1.54 | -1.68 |
| EPS Diluted Continuous Ops | -1.59 | -1.85 | -1.72 | -1.21 | -1.71 |
| EBITDA(a) | $-11,103 | $-13,535 | $-12,482 | $-9,473 | $-11,970 |